Eye on the Market: The Verdict
Michael discusses US-China trade war in context, the outlook for prescription drug price legislation, and an updated ideological scorecard for 2020 Presidential candidates.
Our 2019 Global Alternatives Outlook (PDF) has ideas to help you navigate this shifting investment landscape in the upcoming 12- to 18-months.
This paper considers the role an enhanced allocation to real assets can play in portfolios during various stages of the pension life cycle.
The how and why of diversification
Michael discusses how short covering, rather than real money, has driven the fastest recovery on record following a bear market, and looks ahead at slowing earnings growth.
New dimensions of diversification
One session exploring healthcare investment was a CIO panel featuring Jacque Millard, Leslie Lenzo and John Barker.
A close look at the Progressive Agenda, China’s deteriorating welcome mat in DC and US Tech IPOs.
For the first time in 20 years, markets will have to survive without support from central banks.